nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PPARG—forelimb—amyotrophic lateral sclerosis	0.029	0.118	CbGeAlD
Nateglinide—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.027	0.072	CcSEcCtD
Nateglinide—PPARG—hindlimb—amyotrophic lateral sclerosis	0.0261	0.106	CbGeAlD
Nateglinide—PPARG—appendage—amyotrophic lateral sclerosis	0.0224	0.0907	CbGeAlD
Nateglinide—Injury—Riluzole—amyotrophic lateral sclerosis	0.0194	0.0517	CcSEcCtD
Nateglinide—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0189	0.0506	CcSEcCtD
Nateglinide—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0499	CcSEcCtD
Nateglinide—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0475	CcSEcCtD
Nateglinide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0411	CcSEcCtD
Nateglinide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0395	CcSEcCtD
Nateglinide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0359	CcSEcCtD
Nateglinide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0357	CcSEcCtD
Nateglinide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0351	CcSEcCtD
Nateglinide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.013	0.0346	CcSEcCtD
Nateglinide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0324	CcSEcCtD
Nateglinide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0311	CcSEcCtD
Nateglinide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0297	CcSEcCtD
Nateglinide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0286	CcSEcCtD
Nateglinide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0277	CcSEcCtD
Nateglinide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.01	0.0268	CcSEcCtD
Nateglinide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00947	0.0253	CcSEcCtD
Nateglinide—Cough—Riluzole—amyotrophic lateral sclerosis	0.00935	0.025	CcSEcCtD
Nateglinide—ABCC8—brainstem—amyotrophic lateral sclerosis	0.00892	0.0362	CbGeAlD
Nateglinide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00846	0.0226	CcSEcCtD
Nateglinide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0077	0.0206	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00755	0.0202	CcSEcCtD
Nateglinide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00754	0.0201	CcSEcCtD
Nateglinide—PPARG—embryo—amyotrophic lateral sclerosis	0.00743	0.0301	CbGeAlD
Nateglinide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0191	CcSEcCtD
Nateglinide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00695	0.0186	CcSEcCtD
Nateglinide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00692	0.0185	CcSEcCtD
Nateglinide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0172	CcSEcCtD
Nateglinide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00628	0.0168	CcSEcCtD
Nateglinide—ABCC8—medulla oblongata—amyotrophic lateral sclerosis	0.00622	0.0252	CbGeAlD
Nateglinide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00619	0.0165	CcSEcCtD
Nateglinide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00599	0.016	CcSEcCtD
Nateglinide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00578	0.0154	CcSEcCtD
Nateglinide—SLC16A1—medulla oblongata—amyotrophic lateral sclerosis	0.00566	0.0229	CbGeAlD
Nateglinide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00556	0.0149	CcSEcCtD
Nateglinide—ABCC8—spinal cord—amyotrophic lateral sclerosis	0.00555	0.0225	CbGeAlD
Nateglinide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00552	0.0147	CcSEcCtD
Nateglinide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00551	0.0147	CcSEcCtD
Nateglinide—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00522	0.0212	CbGeAlD
Nateglinide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0052	0.0139	CcSEcCtD
Nateglinide—KCNJ11—nervous system—amyotrophic lateral sclerosis	0.00508	0.0206	CbGeAlD
Nateglinide—SLC16A1—spinal cord—amyotrophic lateral sclerosis	0.00505	0.0205	CbGeAlD
Nateglinide—KCNJ11—central nervous system—amyotrophic lateral sclerosis	0.00489	0.0198	CbGeAlD
Nateglinide—KCNJ11—cerebellum—amyotrophic lateral sclerosis	0.00478	0.0194	CbGeAlD
Nateglinide—ABCC8—nervous system—amyotrophic lateral sclerosis	0.00468	0.0189	CbGeAlD
Nateglinide—ORM1—spinal cord—amyotrophic lateral sclerosis	0.00453	0.0184	CbGeAlD
Nateglinide—ABCC8—central nervous system—amyotrophic lateral sclerosis	0.0045	0.0182	CbGeAlD
Nateglinide—ABCC8—cerebellum—amyotrophic lateral sclerosis	0.0044	0.0178	CbGeAlD
Nateglinide—SLC16A1—nervous system—amyotrophic lateral sclerosis	0.00425	0.0172	CbGeAlD
Nateglinide—SLC22A6—brain—amyotrophic lateral sclerosis	0.0041	0.0166	CbGeAlD
Nateglinide—SLC16A1—central nervous system—amyotrophic lateral sclerosis	0.0041	0.0166	CbGeAlD
Nateglinide—SLC16A1—cerebellum—amyotrophic lateral sclerosis	0.004	0.0162	CbGeAlD
Nateglinide—KCNJ11—brain—amyotrophic lateral sclerosis	0.00388	0.0157	CbGeAlD
Nateglinide—ORM1—nervous system—amyotrophic lateral sclerosis	0.00382	0.0155	CbGeAlD
Nateglinide—SLC15A2—medulla oblongata—amyotrophic lateral sclerosis	0.00372	0.0151	CbGeAlD
Nateglinide—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00368	0.0149	CbGeAlD
Nateglinide—ABCC8—brain—amyotrophic lateral sclerosis	0.00357	0.0145	CbGeAlD
Nateglinide—PPARG—nervous system—amyotrophic lateral sclerosis	0.00357	0.0145	CbGeAlD
Nateglinide—PPARG—central nervous system—amyotrophic lateral sclerosis	0.00344	0.0139	CbGeAlD
Nateglinide—SLC15A2—spinal cord—amyotrophic lateral sclerosis	0.00332	0.0134	CbGeAlD
Nateglinide—SLC16A1—brain—amyotrophic lateral sclerosis	0.00325	0.0132	CbGeAlD
Nateglinide—ABCC4—nervous system—amyotrophic lateral sclerosis	0.00324	0.0131	CbGeAlD
Nateglinide—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.00312	0.0126	CbGeAlD
Nateglinide—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00299	0.0121	CbGeAlD
Nateglinide—SLC15A2—nervous system—amyotrophic lateral sclerosis	0.00279	0.0113	CbGeAlD
Nateglinide—PPARG—brain—amyotrophic lateral sclerosis	0.00273	0.0111	CbGeAlD
Nateglinide—SLC15A2—central nervous system—amyotrophic lateral sclerosis	0.00269	0.0109	CbGeAlD
Nateglinide—SLC15A2—cerebellum—amyotrophic lateral sclerosis	0.00263	0.0107	CbGeAlD
Nateglinide—ALB—brain—amyotrophic lateral sclerosis	0.00256	0.0104	CbGeAlD
Nateglinide—ABCC4—brain—amyotrophic lateral sclerosis	0.00248	0.01	CbGeAlD
Nateglinide—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.00226	0.00918	CbGeAlD
Nateglinide—SLC15A2—brain—amyotrophic lateral sclerosis	0.00214	0.00865	CbGeAlD
Nateglinide—PTGS1—nervous system—amyotrophic lateral sclerosis	0.00191	0.00773	CbGeAlD
Nateglinide—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.00184	0.00744	CbGeAlD
Nateglinide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00159	0.00646	CbGeAlD
Nateglinide—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00157	0.00635	CbGeAlD
Nateglinide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00153	0.00622	CbGeAlD
Nateglinide—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00151	0.00612	CbGeAlD
Nateglinide—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00148	0.00598	CbGeAlD
Nateglinide—PTGS1—brain—amyotrophic lateral sclerosis	0.00146	0.00591	CbGeAlD
Nateglinide—CYP2D6—brain—amyotrophic lateral sclerosis	0.0012	0.00486	CbGeAlD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00068	0.0018	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000678	0.00179	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000678	0.00179	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000675	0.00178	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000669	0.00177	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000668	0.00176	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000663	0.00175	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000662	0.00175	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000656	0.00173	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000656	0.00173	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000651	0.00172	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—DAO—amyotrophic lateral sclerosis	0.000642	0.00169	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000641	0.00169	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00064	0.00169	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000633	0.00167	CbGpPWpGaD
Nateglinide—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000619	0.00163	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000612	0.00162	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000611	0.00161	CbGpPWpGaD
Nateglinide—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00061	0.00161	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000606	0.0016	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000606	0.0016	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000605	0.0016	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0006	0.00158	CbGpPWpGaD
Nateglinide—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.0006	0.00158	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000592	0.00156	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000585	0.00154	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000578	0.00153	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000578	0.00153	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000566	0.00149	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000564	0.00149	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000564	0.00149	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000564	0.00149	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000558	0.00147	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000552	0.00146	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000544	0.00144	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000543	0.00143	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000531	0.0014	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00053	0.0014	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000527	0.00139	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000526	0.00139	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000525	0.00139	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000516	0.00136	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000516	0.00136	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000515	0.00136	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000504	0.00133	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000504	0.00133	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000502	0.00132	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000496	0.00131	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000494	0.0013	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000486	0.00128	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000479	0.00127	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000479	0.00127	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000478	0.00126	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	0.000474	0.00125	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000474	0.00125	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000474	0.00125	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000465	0.00123	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000463	0.00122	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000461	0.00122	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00046	0.00121	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00046	0.00121	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000459	0.00121	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000451	0.00119	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GSR—amyotrophic lateral sclerosis	0.000449	0.00119	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000449	0.00118	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000447	0.00118	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000444	0.00117	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000443	0.00117	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000443	0.00117	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000442	0.00117	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000441	0.00116	CbGpPWpGaD
Nateglinide—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000439	0.00116	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000435	0.00115	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000434	0.00115	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000434	0.00115	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000429	0.00113	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000423	0.00112	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00042	0.00111	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000408	0.00108	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000403	0.00106	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000391	0.00103	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000383	0.00101	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00038	0.001	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000379	0.001	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000369	0.000973	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000368	0.000971	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000367	0.00097	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000363	0.000959	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000363	0.000959	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00036	0.000949	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000356	0.000939	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000344	0.000909	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000343	0.000905	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000343	0.000905	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000343	0.000905	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000341	0.000901	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000332	0.000877	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	0.000332	0.000876	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00033	0.000871	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000323	0.000853	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000318	0.00084	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000315	0.000833	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000314	0.000828	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000314	0.000828	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000311	0.000821	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000309	0.000816	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000308	0.000813	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000302	0.000798	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000301	0.000795	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000297	0.000785	CbGpPWpGaD
Nateglinide—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000295	0.000779	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000295	0.000779	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000291	0.00077	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.00029	0.000766	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00029	0.000765	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000285	0.000753	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000284	0.000751	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000276	0.00073	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000275	0.000727	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000274	0.000724	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000272	0.000719	CbGpPWpGaD
Nateglinide—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00027	0.000713	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000262	0.000691	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000262	0.000691	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00026	0.000686	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00026	0.000686	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000256	0.000675	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000252	0.000665	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000251	0.000663	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000249	0.000656	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000248	0.000654	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000244	0.000644	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000244	0.000644	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000242	0.000638	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000242	0.000638	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.00024	0.000633	CbGpPWpGaD
Nateglinide—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000236	0.000623	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000234	0.000618	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000233	0.000616	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000233	0.000615	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000232	0.000614	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000225	0.000595	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000224	0.000592	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000223	0.000589	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000221	0.000584	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000214	0.000564	CbGpPWpGaD
Nateglinide—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000213	0.000564	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000212	0.000559	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000208	0.000549	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000207	0.000547	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000205	0.000543	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000205	0.000542	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000204	0.00054	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000198	0.000523	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000197	0.00052	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000197	0.00052	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000197	0.000519	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000195	0.000516	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000195	0.000515	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000193	0.00051	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000191	0.000504	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000188	0.000496	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000188	0.000496	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000182	0.000481	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000179	0.000474	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000176	0.000465	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000175	0.000461	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000174	0.00046	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000173	0.000458	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00017	0.00045	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000167	0.000442	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000166	0.00044	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000162	0.000427	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000159	0.000421	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000159	0.000421	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—APOE—amyotrophic lateral sclerosis	0.000155	0.000408	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.00015	0.000397	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—APOE—amyotrophic lateral sclerosis	0.00015	0.000396	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000149	0.000394	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000149	0.000394	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000149	0.000392	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000148	0.00039	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000147	0.000387	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000146	0.000387	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000146	0.000387	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000146	0.000385	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000142	0.000376	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000136	0.000359	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000136	0.000358	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000135	0.000355	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000134	0.000353	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000132	0.00035	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000129	0.00034	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000127	0.000336	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000126	0.000332	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000123	0.000325	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000123	0.000324	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000122	0.000323	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000119	0.000315	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000116	0.000305	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000115	0.000304	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000112	0.000295	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000111	0.000294	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000111	0.000292	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	0.000111	0.000292	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000106	0.00028	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000106	0.000279	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000103	0.000271	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000103	0.000271	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000102	0.000268	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000101	0.000267	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000101	0.000267	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.0001	0.000265	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.73e-05	0.000257	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	9.51e-05	0.000251	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.43e-05	0.000249	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.16e-05	0.000242	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	8.73e-05	0.000231	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	8.06e-05	0.000213	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	8e-05	0.000211	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	7.76e-05	0.000205	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.66e-05	0.000202	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.65e-05	0.000202	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.59e-05	0.0002	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.03e-05	0.000186	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	6.63e-05	0.000175	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.62e-05	0.000175	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.59e-05	0.000174	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.52e-05	0.000172	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.27e-05	0.000166	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.05e-05	0.00016	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	5.78e-05	0.000153	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.48e-05	0.000145	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.44e-05	0.000144	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.39e-05	0.000142	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.31e-05	0.00014	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	5.01e-05	0.000132	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5e-05	0.000132	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	4.98e-05	0.000132	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.96e-05	0.000131	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.11e-05	0.000109	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.08e-05	0.000108	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.96e-05	0.000105	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.56e-05	9.39e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.41e-05	9.01e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.27e-05	8.63e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.82e-05	7.44e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.79e-05	7.38e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.69e-05	7.1e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.84e-05	4.87e-05	CbGpPWpGaD
